ARTICLE | Management Tracks
Arcturus appoints Slaoui chair designate
Plus: Affinia hires Makimura and Xu joins Sciwind
February 6, 2025 2:26 AM UTC
mRNA company Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) appointed Moncef Slaoui chair designate. Slaoui was most recently chief scientific adviser to Operation Warp Speed and joined Arcturus’ board in 2024.
Affinia Therapeutics Inc., which is developing gene therapies, hired Hideo Makimura as CMO. Makimura was VP and global head, specialty ophthalmology R&D at Johnson & Johnson (NYSE:JNJ)...